Eli Lilly and Company (LLY)
Россия
  • Россия
  • Украина

Eli Lilly and Company (LLY)

Contact Details

Lilly Corporate Center, Indianapolis, Indiana, USA 46285-0001
(317) 276-2000
Lilly Corporate Center, Indianapolis, Indiana, USA 46285-0001

General Information

Eli Lilly and Company discovers, develops, manufactures, and sells products in one significant business segment -pharmaceutical products. The company directs its research efforts primarily toward the search for products to diagnose, prevent and treat human diseases. The company also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

Contact Information

Phone(317) 276-2000
Customer Service Phone(317) 276-2000
Fax(317) 276-0120
Website 1http://www.lilly.com
Website 2http://www.hrresearch.org
Website 3http://www.lillydirect.com
FacebookFacebook
LinkedInLinkedIn
Twitter@EliLillyCo
Thomson Reuters PermID4295904414

Executives

NamePositionTotal Annual CompensationYearPercent Change in Compensation
Dr. John C Lechleiter PhDCEO, Chairman of the Board and President$14,481,142201429.1%
Dr. Jan M. Lundberg, PhDCFO and Divisional President$4,607,0962014-3.5%
Enrique A. ConternoDivisional President and Senior VP$3,895,044201429.4%
Michael J. HarringtonGeneral Counsel and Senior VP$4,054,174201427.7%
Mr. Derica W. RiceCFO and Divisional Executive VP$6,734,411201430.1%

Government Contracts

Largest Contracts

AgencyProduct or ServiceSigned DateObligation Amount
Department of Veterans AffairsMedical and Surgical Instruments, Equipment and SuppliesOctober 25, 2007$211,785
Department of Veterans AffairsDrugs and BiologicalsApril 05, 2005$71,346
Department of Veterans AffairsMedical and Surgical Instruments, Equipment and SuppliesJuly 01, 2005$55,200
Department of Veterans AffairsMedical and Surgical Instruments, Equipment and SuppliesJanuary 15, 2003$47,000
Department of Veterans AffairsMedical and Surgical Instruments, Equipment and SuppliesMarch 22, 2007$37,600

Corporate Data

Industries

  • Pharmaceutical Preparation Manufacturing

SIC Industries

  • Pharmaceutical Preparations

Company Size

Sales Volume$20 billion
Employees41,275

Ownership

Ticker SymbolLLY
ExchangeNew York Stock Exchange (NYSE)
Type of EntityFor Profit Organization
Type of OwnershipNot Tax Exempt Corporate Entity
Other CategorizationsManufacturer of Goods
Year Founded1876

Stocks

Previous Close74.39
Open74.48
Bid70.50 x 100
Ask74.75 x 100
Day`s Range73.80 - 74.74
52-Week Range69.06 - 89.98
Average Volume (1M)5,124,265
Forward P/E21.01x
Trailing P/E21.63x
Beta0.2x
Market Cap.$82,163.2 Million
Dividend & Yield2.04 (2.74%)
Last Dividend Amount0.5
1y Target Price Est.92.9

Financials

Period EndingDec. 31, 2015Sep. 30, 2015Jun. 30, 2015Mar. 31, 2015
Total Revenue5,375,5994,959,7004,978,7004,644,700
Cost of Revenue1,389,2001,236,9001,218,4001,192,700
Gross Profit3,986,3983,722,8003,760,3003,452,000
Research Development1,444,2001,143,4001,169,5001,039,300
Selling General and Administrative1,798,4001,575,7001,635,4001,523,500
Depreciation and Amortization----
Other Operating Expenses566,699-80,000256,000
Total Operating Expenses5,198,4993,956,0004,103,3004,011,500
Other Income/Expenses Net----
Earnings Before Interest and Taxes177,099.61,003,700875,400.4633,200.2
Interest Expense----
Income Before Tax444,6001,047,800679,700617,900
Income Tax Expense(33,800)248,10078,90088,400
Minority Interest----
Net Income from Continuing Ops478,399.8799,700.1600,800529,500
Discontinued Operations----
Extraordinary Items----
Effect of Accounting Changes----
Other Items----
Net Income478,399.8799,700.1600,800529,500
Preferred Stock and Other Adjustments-0.1--
Net Income Applicable to Common Shares478,400799,700600,800529,500